| MOBoxy: MoblO2 to Maintain Oxygenation (NCT07222592) | National Jewish Health | 2025-12-01 |
| Enhancing Hypnotic Medication Discontinuation in Primary Care (NCT06435520) | National Jewish Health | 2025-01-01 |
| Effect of Omalizumab in the Skin of Food Allergy Patients (NCT06618963) | National Jewish Health | 2024-10-01 |
| Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma (NCT06270576) | National Jewish Health | 2024-04-01 |
| Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria (NCT06262282) | National Jewish Health | 2024-02-05 |
| Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY (NCT05822102) | National Jewish Health | 2023-02-09 |
| Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study (NCT04724278) | National Jewish Health | 2021-02-05 |
| COVID-19 Vaccine Response in Chronic Respiratory Conditions (NCT05313087) | National Jewish Health | 2021-02-03 |
| Creation of Home-based Asthma Real-World Measures With Mobile Health Study (NCT04462224) | National Jewish Health | 2021-01-11 |
| A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis (NCT04844359) | National Jewish Health | 2021-01-06 |
| Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD (NCT04535245) | National Jewish Health | 2021-01-04 |
| Hand Sanitizer Effects on the Skin Barrier (NCT04525521) | National Jewish Health | 2020-12-01 |
| Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis (NCT04598919) | National Jewish Health | 2020-11-12 |
| Skin Barrier Abnormalities and Oxidative Stress Response (NCT04606615) | National Jewish Health | 2020-10-16 |
| Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy (NCT04283539) | National Jewish Health | 2020-09-23 |
| Skin Barrier Assessment in Pregnancy and at Birth (NCT04445298) | National Jewish Health | 2020-08-03 |
| Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations (NCT04341532) | National Jewish Health | 2020-02-20 |
| Use of DNAse in Neutrophilic Asthma (NCT03994380) | National Jewish Health | 2020-02-12 |
| Skin Characteristics of Parents of Food Allergic Pediatric Patients (NCT04198753) | National Jewish Health | 2020-01-23 |
| Skin Tape Transcriptome Methods in Children (NCT04180644) | National Jewish Health | 2020-01-10 |
| Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum (NCT04060550) | National Jewish Health | 2020-01-09 |
| Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations (NCT04354038) | National Jewish Health | 2020-01-07 |
| Asthma and Intimate Partner Violence (NCT04216680) | National Jewish Health | 2020-01-02 |
| Use of Blinded Tapering for Hypnotic Discontinuation (NCT04050176) | National Jewish Health | 2019-12-16 |
| Macrophage Programing in Acute Lung Injury (NCT03844893) | National Jewish Health | 2019-10-01 |
| Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs (NCT04353752) | National Jewish Health | 2019-09-16 |
| Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease. (NCT04038710) | National Jewish Health | 2019-09-05 |
| Sildenafil Exercise: Role of PDE5 Inhibition (NCT04039087) | National Jewish Health | 2019-09-05 |
| Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction Study (NCT04942548) | National Jewish Health | 2019-07-25 |
| Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis (NCT04024423) | National Jewish Health | 2019-07-01 |
| Alveolar Macrophage Programming Following Endotoxin Exposure (NCT03859050) | National Jewish Health | 2019-03-18 |
| The Role of Bacterial Toxins in Human Skin Disease (NCT02910791) | National Jewish Health | 2019-02-20 |
| Synovial Fluid Biomarkers Pre and Post Hymovis Knee Injection (NCT04093232) | National Jewish Health | 2019-01-01 |
| Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) (NCT02323100) | National Jewish Health | 2018-12-02 |
| Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD) (NCT04261582) | National Jewish Health | 2018-11-06 |
| The Role of Laryngopharyngeal Reflux in IPF (NCT03418350) | National Jewish Health | 2018-08-01 |
| Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus (NCT03746197) | National Jewish Health | 2018-06-06 |
| Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis (NCT03560726) | National Jewish Health | 2018-06-04 |
| Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time (NCT03616158) | National Jewish Health | 2018-05-10 |
| Interstitial Lung Disease in Early Rheumatoid Arthritis (NCT03977415) | National Jewish Health | 2018-03-27 |
| : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva) (NCT03445793) | National Jewish Health | 2018-03-01 |
| Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy (NCT03089476) | National Jewish Health | 2017-09-30 |
| Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study (NCT02947945) | National Jewish Health | 2017-09-12 |
| An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation (NCT03377647) | National Jewish Health | 2017-08-01 |
| Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease (NCT03241420) | National Jewish Health | 2017-04-24 |
| Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study (NCT03010436) | National Jewish Health | 2017-04-15 |
| Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea (NCT03109210) | National Jewish Health | 2017-04-15 |
| Changing School Start Times: Impact on Student, Family, Teacher, and Community Health (NCT03964181) | National Jewish Health | 2017-04-11 |
| Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma (NCT02753764) | National Jewish Health | 2017-01-01 |
| The Breathe Well Program for Adults With Asthma (NCT02761837) | National Jewish Health | 2016-10-01 |
| IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy (NCT02918409) | National Jewish Health | 2016-08-26 |
| Pneumococcal Post-Vaccination Titers (NCT02726347) | National Jewish Health | 2016-04-01 |
| Identification of Epidermal Signatures in Patients With Atopic Dermatitis (NCT02680405) | National Jewish Health | 2016-04-01 |
| Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis (NCT03145922) | National Jewish Health | 2016-01-01 |
| Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency (NCT02691611) | National Jewish Health | 2015-12-01 |
| Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF (NCT02626182) | National Jewish Health | 2015-12-01 |
| The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation (NCT02831894) | National Jewish Health | 2015-11-02 |
| Effects of Sildenafil on CFTR-dependent Ion Transport Activity (NCT01132482) | National Jewish Health | 2015-10-01 |
| T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease (NCT04397861) | National Jewish Health | 2015-05-06 |
| The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD) (NCT02596347) | National Jewish Health | 2015-04-01 |
| Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD) (NCT02604693) | National Jewish Health | 2014-12-14 |
| Tailored Treatment to Enhance Risk Perception in Sleep Apnea (NCT02314858) | National Jewish Health | 2014-10-01 |
| Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis (NCT04397809) | National Jewish Health | 2014-09-10 |
| Colorado Marijuana Users Health Cohort (NCT02735954) | National Jewish Health | 2014-09-01 |
| Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension (NCT02220634) | National Jewish Health | 2014-08-01 |
| Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease (NCT03012958) | National Jewish Health | 2014-07-01 |
| Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea (NCT02097212) | National Jewish Health | 2014-03-01 |
| PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (NCT02419989) | National Jewish Health | 2014-01-01 |
| PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis (NCT02073409) | National Jewish Health | 2013-12-01 |
| COPDGene/Lung Cancer Center Database (NCT02445183) | National Jewish Health | 2013-12-01 |
| Supplemental Oxygen in Pulmonary Fibrosis (NCT01961362) | National Jewish Health | 2013-10-01 |
| The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy (NCT01950533) | National Jewish Health | 2013-09-01 |
| FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults (NCT01950494) | National Jewish Health | 2013-09-01 |
| Pulmonary Fibrosis Contact Registry (NCT01935726) | National Jewish Health | 2013-08-01 |
| Deployment-Related Lung Disease Research Database and Biorepository (NCT03035097) | National Jewish Health | 2013-02-01 |
| Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution (NCT01736839) | National Jewish Health | 2012-11-01 |
| Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension (NCT02169752) | National Jewish Health | 2012-09-01 |
| Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker (NCT01700257) | National Jewish Health | 2012-05-01 |
| Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) (NCT01253473) | National Jewish Health | 2012-04-01 |
| Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma (NCT01589198) | National Jewish Health | 2012-01-01 |
| The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis (NCT01587001) | National Jewish Health | 2011-11-01 |
| Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension (NCT01491646) | National Jewish Health | 2010-11-01 |
| Dog Hair Extract Study (NCT01343420) | National Jewish Health | 2010-11-01 |
| Phase II Study of Digitoxin to Treat Cystic Fibrosis (NCT00782288) | National Jewish Health | 2010-08-01 |
| Targeting Oxidative Stress in Chronic Beryllium Disease (NCT01088243) | National Jewish Health | 2010-03-01 |
| Sub-Sensitivity to Long-Acting Bronchodilators (LABA) (NCT01117116) | National Jewish Health | 2010-03-01 |
| Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device (NCT01234077) | National Jewish Health | 2010-03-01 |
| Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis (NCT01107028) | National Jewish Health | 2010-02-01 |
| Telecommunication Enhanced Asthma Management (NCT00958932) | National Jewish Health | 2009-09-01 |
| Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels (NCT00851370) | National Jewish Health | 2009-01-01 |
| Progression of Airway Obstruction in Childhood Asthma (NCT00873873) | National Jewish Health | 2008-09-01 |
| Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease (NCT00659529) | National Jewish Health | 2008-08-01 |
| Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) (NCT01088217) | National Jewish Health | 2008-07-01 |
| Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen (NCT00738569) | National Jewish Health | 2008-07-01 |
| Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD) (NCT00700921) | National Jewish Health | 2008-04-01 |
| Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis (NCT00692796) | National Jewish Health | 2008-04-01 |
| Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies (NCT00727285) | National Jewish Health | 2008-02-01 |
| Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study) (NCT00623246) | National Jewish Health | 2007-12-01 |
| Markers of Airway Inflammation in BAL Fluid From Children With Asthma (NCT00838552) | National Jewish Health | 2007-10-01 |
| Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications (NCT00557180) | National Jewish Health | 2007-10-01 |